{"id":9472,"date":"2017-10-12T14:33:04","date_gmt":"2017-10-12T14:33:04","guid":{"rendered":"http:\/\/ipsinternational.org\/fi\/news.asp?idnews=6624"},"modified":"2017-10-12T14:33:04","modified_gmt":"2017-10-12T14:33:04","slug":"terveys-uusilla-antibiooteilla-on-kiire","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/","title":{"rendered":"TERVEYS: Uusilla antibiooteilla on kiire"},"content":{"rendered":"<p>Rooma, 09.10.17 (IPS) &#8211; Maailma tarvitsee pikaisesti uusia antibiootteja korvaamaan niit\u00e4, joille bakteerit ovat kehitt\u00e4neet resistenssin, Maailman terveysj\u00e4rjest\u00f6 WHO:n varoittaa.<\/p>\n<p><!--more--><\/p>\n<p>L\u00e4\u00e4kkeiden tutkimukseen ja kehitykseen on sijoitettava lis\u00e4\u00e4 rahaa tai paalaamme aikaan, jolloin tuberkuloosi, tavalliset tulehdussairaudet tai pienet leikkaukset olivat hengenvaarallisia, WHO:n p\u00e4\u00e4johtaja Tedros Adhanom Ghebreyesus sanoo.<\/p>\n<p>WHO arvioi, ett\u00e4 kehittelyss\u00e4 olevista 51 l\u00e4\u00e4kkeest\u00e4 vain kahdeksalla on todellista merkityst\u00e4 antibioottiresistenssin kannalta. J\u00e4rjest\u00f6 perusti syyskuussa uuden yhteisty\u00f6elimen vauhdittamaan l\u00e4\u00e4kekehityst\u00e4. Valtiot ja s\u00e4\u00e4ti\u00f6t lupasivat sille 56 miljoonan euron alkup\u00e4\u00e4oman. Yksin tuberkuloosin tutkimus vaatisi kuitenkin 800 miljoonaa euroa vuodessa.<\/p>\n<p>(Inter Press Service)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rooma, 09.10.17 (IPS) &#8211; Maailma tarvitsee pikaisesti uusia antibiootteja korvaamaan niit\u00e4, joille bakteerit ovat kehitt\u00e4neet resistenssin, Maailman terveysj\u00e4rjest\u00f6 WHO:n varoittaa.<\/p>\n<p>L\u00e4\u00e4kkeiden tutkimukseen ja kehitykseen on sijoitettava lis\u00e4\u00e4 r&#8230; <a href=\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":310,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,5,3,23,16],"tags":[],"coauthors":[],"class_list":["post-9472","post","type-post","status-publish","format-standard","hentry","category-globaalit-aiheet","category-kehitys","category-talous","category-terveys","category-tiede-teknologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE\" \/>\n<meta property=\"og:description\" content=\"Rooma, 09.10.17 (IPS) - Maailma tarvitsee pikaisesti uusia antibiootteja korvaamaan niit\u00e4, joille bakteerit ovat kehitt\u00e4neet resistenssin, Maailman terveysj\u00e4rjest\u00f6 WHO:n varoittaa. L\u00e4\u00e4kkeiden tutkimukseen ja kehitykseen on sijoitettava lis\u00e4\u00e4 r... Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\" \/>\n<meta property=\"og:site_name\" content=\"INTER PRESS SERVICE\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-12T14:33:04+00:00\" \/>\n<meta name=\"author\" content=\"Baher Kamal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Baher Kamal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\",\"url\":\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\",\"name\":\"TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/suomi\/#website\"},\"datePublished\":\"2017-10-12T14:33:04+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/a4490b881295f3324ea2b22a08b4427f\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/suomi\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TERVEYS: Uusilla antibiooteilla on kiire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/suomi\/#website\",\"url\":\"https:\/\/ipsnews.net\/suomi\/\",\"name\":\"INTER PRESS SERVICE\",\"description\":\"Uutistoimisto\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/suomi\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/a4490b881295f3324ea2b22a08b4427f\",\"name\":\"Baher Kamal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/image\/e9b1fa7d18dbe76ee5152453ca4d14a7\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/dbbd65e49a26bb6d39f0828892901d36fc62c94c2ac323d171ea6745cf0256f9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/dbbd65e49a26bb6d39f0828892901d36fc62c94c2ac323d171ea6745cf0256f9?s=96&d=mm&r=g\",\"caption\":\"Baher Kamal\"},\"sameAs\":[\"http:\/\/ipsinternational.org\/fi\/\"],\"url\":\"https:\/\/ipsnews.net\/suomi\/author\/baher-kamal\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/","og_locale":"en_US","og_type":"article","og_title":"TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE","og_description":"Rooma, 09.10.17 (IPS) - Maailma tarvitsee pikaisesti uusia antibiootteja korvaamaan niit\u00e4, joille bakteerit ovat kehitt\u00e4neet resistenssin, Maailman terveysj\u00e4rjest\u00f6 WHO:n varoittaa. L\u00e4\u00e4kkeiden tutkimukseen ja kehitykseen on sijoitettava lis\u00e4\u00e4 r... Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/","og_site_name":"INTER PRESS SERVICE","article_published_time":"2017-10-12T14:33:04+00:00","author":"Baher Kamal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Baher Kamal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/","url":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/","name":"TERVEYS: Uusilla antibiooteilla on kiire - INTER PRESS SERVICE","isPartOf":{"@id":"https:\/\/ipsnews.net\/suomi\/#website"},"datePublished":"2017-10-12T14:33:04+00:00","author":{"@id":"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/a4490b881295f3324ea2b22a08b4427f"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/suomi\/2017\/10\/12\/terveys-uusilla-antibiooteilla-on-kiire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/suomi\/"},{"@type":"ListItem","position":2,"name":"TERVEYS: Uusilla antibiooteilla on kiire"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/suomi\/#website","url":"https:\/\/ipsnews.net\/suomi\/","name":"INTER PRESS SERVICE","description":"Uutistoimisto","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/suomi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/a4490b881295f3324ea2b22a08b4427f","name":"Baher Kamal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/suomi\/#\/schema\/person\/image\/e9b1fa7d18dbe76ee5152453ca4d14a7","url":"https:\/\/secure.gravatar.com\/avatar\/dbbd65e49a26bb6d39f0828892901d36fc62c94c2ac323d171ea6745cf0256f9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dbbd65e49a26bb6d39f0828892901d36fc62c94c2ac323d171ea6745cf0256f9?s=96&d=mm&r=g","caption":"Baher Kamal"},"sameAs":["http:\/\/ipsinternational.org\/fi\/"],"url":"https:\/\/ipsnews.net\/suomi\/author\/baher-kamal\/"}]}},"_links":{"self":[{"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/posts\/9472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/users\/310"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/comments?post=9472"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/posts\/9472\/revisions"}],"predecessor-version":[{"id":9473,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/posts\/9472\/revisions\/9473"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/media?parent=9472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/categories?post=9472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/tags?post=9472"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/ipsnews.net\/suomi\/wp-json\/wp\/v2\/coauthors?post=9472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}